IOVA

Iovance Biotherapeutics, INC.

Insider trading activity for Iovance Biotherapeutics, INC., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 100 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Sep 8	Puri Raj K.	Chief Regulatory Officer	MEXER◆	9,766	—	—	—	Open the original filing on SEC.gov
Sep 8	Puri Raj K.	Chief Regulatory Officer	FTAX	4,478	$8.70	$39K	-1.7%	Open the original filing on SEC.gov
Sep 8	Puri Raj K.	Chief Regulatory Officer	MEXER	9,766	—	—	+3.9%	Open the original filing on SEC.gov
Sep 8	Bilinsky Igor	Chief Operating Officer	MEXER◆	7,813	—	—	—	Open the original filing on SEC.gov
Sep 8	Bilinsky Igor	Chief Operating Officer	FTAX	3,976	$8.70	$34.6K	-2.7%	Open the original filing on SEC.gov
Sep 8	Bilinsky Igor	Chief Operating Officer	MEXER	7,813	—	—	+5.7%	Open the original filing on SEC.gov
Sep 8	Vogt Frederick G	Interim CEO & General…	MEXER◆	15,626	—	—	—	Open the original filing on SEC.gov
Sep 8	Vogt Frederick G	Interim CEO & General…	FTAX	6,638	$8.70	$57.8K	-1.1%	Open the original filing on SEC.gov
Sep 8	Vogt Frederick G	Interim CEO & General…	MEXER	15,626	—	—	+2.7%	Open the original filing on SEC.gov
Sep 1	Bilinsky Igor	Chief Operating Officer	MEXER◆	8,789	—	—	—	Open the original filing on SEC.gov
Sep 1	Bilinsky Igor	Chief Operating Officer	FTAX	4,472	$8.28	$37K	-3.1%	Open the original filing on SEC.gov
Sep 1	Bilinsky Igor	Chief Operating Officer	MEXER	8,789	—	—	+6.6%	Open the original filing on SEC.gov
Sep 1	Puri Raj K.	Chief Regulatory Officer	MEXER◆	5,470	—	—	—	Open the original filing on SEC.gov
Sep 1	Puri Raj K.	Chief Regulatory Officer	FTAX	2,508	$8.28	$20.8K	-1.0%	Open the original filing on SEC.gov
Sep 1	Puri Raj K.	Chief Regulatory Officer	MEXER	5,470	—	—	+2.2%	Open the original filing on SEC.gov
Sep 1	Vogt Frederick G	Interim CEO & General…	MEXER◆	41,669	—	—	—	Open the original filing on SEC.gov
Sep 1	Vogt Frederick G	Interim CEO & General…	FTAX	17,702	$8.28	$146.6K	-2.9%	Open the original filing on SEC.gov
Sep 1	Vogt Frederick G	Interim CEO & General…	MEXER	41,669	—	—	+7.4%	Open the original filing on SEC.gov
Aug 10	Kirby Daniel Gordon	Chief Commercial Officer	MEXER◆	10,001	—	—	—	Open the original filing on SEC.gov
Aug 10	Kirby Daniel Gordon	Chief Commercial Officer	FTAX	2,436	$6.40	$15.6K	-1.6%	Open the original filing on SEC.gov
Aug 10	Kirby Daniel Gordon	Chief Commercial Officer	MEXER	10,001	—	—	+6.8%	Open the original filing on SEC.gov
Aug 6	Roche Corleen M.	Chief Financial Officer	MEXER◆	49,995	—	—	—	Open the original filing on SEC.gov
Aug 6	Roche Corleen M.	Chief Financial Officer	FTAX	21,238	$6.21	$131.9K	-42.5%	Open the original filing on SEC.gov
Aug 6	Roche Corleen M.	Chief Financial Officer	MEXER	49,995	—	—	—	Open the original filing on SEC.gov
Jun 16	Weiser Michael	Director	AGRANT◆	90,316	—	—	—	Open the original filing on SEC.gov
Jun 16	Maynard Ryan D	Director	AGRANT◆	90,316	—	—	—	Open the original filing on SEC.gov
Jun 16	Puri Raj K.	Chief Regulatory Officer	AGRANT◆	15,000	—	—	—	Open the original filing on SEC.gov
Jun 16	Dukes Iain D.	Director	AGRANT◆	180,632	—	—	—	Open the original filing on SEC.gov
Jun 16	Countouriotis Athena	Director	AGRANT◆	90,316	—	—	—	Open the original filing on SEC.gov
Jun 5	Vogt Frederick G	Interim CEO & General…	MEXER◆	15,625	—	—	—	Open the original filing on SEC.gov
Jun 5	Vogt Frederick G	Interim CEO & General…	FTAX	6,638	$4.23	$28.1K	-1.2%	Open the original filing on SEC.gov
Jun 5	Vogt Frederick G	Interim CEO & General…	MEXER	15,625	—	—	+2.8%	Open the original filing on SEC.gov
Jun 5	Puri Raj K.	Chief Regulatory Officer	MEXER◆	9,766	—	—	—	Open the original filing on SEC.gov
Jun 5	Puri Raj K.	Chief Regulatory Officer	FTAX	3,843	$4.23	$16.3K	-1.5%	Open the original filing on SEC.gov
Jun 5	Puri Raj K.	Chief Regulatory Officer	MEXER	9,766	—	—	+4.0%	Open the original filing on SEC.gov
Jun 5	Graf Finckenstein…	Chief Medical Officer	MEXER◆	7,813	—	—	—	Open the original filing on SEC.gov
Jun 5	Graf Finckenstein…	Chief Medical Officer	FTAX	3,976	$4.23	$16.8K	-2.8%	Open the original filing on SEC.gov
Jun 5	Graf Finckenstein…	Chief Medical Officer	MEXER	7,813	—	—	+5.7%	Open the original filing on SEC.gov
Jun 5	Bilinsky Igor	Chief Operating Officer	MEXER◆	7,813	—	—	—	Open the original filing on SEC.gov
Jun 5	Bilinsky Igor	Chief Operating Officer	FTAX	3,976	$4.23	$16.8K	-2.9%	Open the original filing on SEC.gov
Jun 5	Bilinsky Igor	Chief Operating Officer	MEXER	7,813	—	—	+6.0%	Open the original filing on SEC.gov
Jun 1	Vogt Frederick G	Interim CEO & General…	MEXER◆	41,668	—	—	—	Open the original filing on SEC.gov
Jun 1	Vogt Frederick G	Interim CEO & General…	FTAX	17,701	$3.96	$70.1K	-3.1%	Open the original filing on SEC.gov
Jun 1	Vogt Frederick G	Interim CEO & General…	MEXER	41,668	—	—	+7.9%	Open the original filing on SEC.gov
Jun 1	Puri Raj K.	Chief Regulatory Officer	MEXER◆	5,469	—	—	—	Open the original filing on SEC.gov
Jun 1	Puri Raj K.	Chief Regulatory Officer	FTAX	2,508	$3.96	$9.9K	-1.0%	Open the original filing on SEC.gov
Jun 1	Puri Raj K.	Chief Regulatory Officer	MEXER	5,469	—	—	+2.3%	Open the original filing on SEC.gov
Jun 1	Graf Finckenstein…	Chief Medical Officer	MEXER◆	8,790	—	—	—	Open the original filing on SEC.gov
Jun 1	Graf Finckenstein…	Chief Medical Officer	FTAX	4,473	$3.96	$17.7K	-3.2%	Open the original filing on SEC.gov
Jun 1	Graf Finckenstein…	Chief Medical Officer	MEXER	8,790	—	—	+6.7%	Open the original filing on SEC.gov
Jun 1	Bilinsky Igor	Chief Operating Officer	MEXER◆	8,790	—	—	—	Open the original filing on SEC.gov
Jun 1	Bilinsky Igor	Chief Operating Officer	FTAX	4,473	$3.96	$17.7K	-3.3%	Open the original filing on SEC.gov
Jun 1	Bilinsky Igor	Chief Operating Officer	MEXER	8,790	—	—	+7.0%	Open the original filing on SEC.gov
May 11	Kirby Daniel Gordon	Chief Commercial Officer	MEXER◆	10,000	—	—	—	Open the original filing on SEC.gov
May 11	Kirby Daniel Gordon	Chief Commercial Officer	FTAX	2,435	$3.70	$9K	-1.6%	Open the original filing on SEC.gov
May 11	Kirby Daniel Gordon	Chief Commercial Officer	MEXER	10,000	—	—	+7.2%	Open the original filing on SEC.gov
Mar 9	Roche Corleen M.	Chief Financial Officer	AGRANT◆	132,200	—	—	—	Open the original filing on SEC.gov
Mar 9	Vogt Frederick G	Interim CEO & General…	AGRANT◆	235,000	—	—	—	Open the original filing on SEC.gov
Mar 9	Puri Raj K.	Chief Regulatory Officer	AGRANT◆	117,500	—	—	—	Open the original filing on SEC.gov
Mar 9	Kirby Daniel Gordon	Chief Commercial Officer	AGRANT◆	132,200	—	—	—	Open the original filing on SEC.gov
Mar 9	Graf Finckenstein…	Chief Medical Officer	AGRANT◆	58,750	—	—	—	Open the original filing on SEC.gov
Mar 9	Bilinsky Igor	Chief Operating Officer	AGRANT◆	117,500	—	—	—	Open the original filing on SEC.gov
Mar 5	Vogt Frederick G	Interim CEO & General…	MEXER◆	62,493	—	—	—	Open the original filing on SEC.gov
Mar 5	Vogt Frederick G	Interim CEO & General…	FTAX	26,755	$4.58	$122.5K	-4.8%	Open the original filing on SEC.gov
Mar 5	Vogt Frederick G	Interim CEO & General…	MEXER	62,493	—	—	+12.7%	Open the original filing on SEC.gov
Mar 5	Puri Raj K.	Chief Regulatory Officer	MEXER◆	39,059	—	—	—	Open the original filing on SEC.gov
Mar 5	Puri Raj K.	Chief Regulatory Officer	FTAX	18,360	$4.58	$84.1K	-7.1%	Open the original filing on SEC.gov
Mar 5	Puri Raj K.	Chief Regulatory Officer	MEXER	39,059	—	—	+17.9%	Open the original filing on SEC.gov
Mar 5	Graf Finckenstein…	Chief Medical Officer	MEXER◆	31,246	—	—	—	Open the original filing on SEC.gov
Mar 5	Graf Finckenstein…	Chief Medical Officer	FTAX	16,520	$4.58	$75.7K	-11.1%	Open the original filing on SEC.gov
Mar 5	Graf Finckenstein…	Chief Medical Officer	MEXER	31,246	—	—	+26.7%	Open the original filing on SEC.gov
Mar 5	Bilinsky Igor	Chief Operating Officer	MEXER◆	31,246	—	—	—	Open the original filing on SEC.gov
Mar 5	Bilinsky Igor	Chief Operating Officer	FTAX	16,628	$4.58	$76.2K	-11.7%	Open the original filing on SEC.gov
Mar 5	Bilinsky Igor	Chief Operating Officer	MEXER	31,246	—	—	+28.1%	Open the original filing on SEC.gov
Mar 2	Vogt Frederick G	Interim CEO & General…	MEXER◆	10,418	—	—	—	Open the original filing on SEC.gov
Mar 2	Vogt Frederick G	Interim CEO & General…	MEXER◆	41,669	—	—	—	Open the original filing on SEC.gov
Mar 2	Vogt Frederick G	Interim CEO & General…	FTAX	22,809	$3.79	$86.4K	-4.4%	Open the original filing on SEC.gov
Mar 2	Vogt Frederick G	Interim CEO & General…	MEXER	52,087	—	—	+11.2%	Open the original filing on SEC.gov
Mar 2	Puri Raj K.	Chief Regulatory Officer	MEXER◆	5,470	—	—	—	Open the original filing on SEC.gov
Mar 2	Puri Raj K.	Chief Regulatory Officer	FTAX	2,798	$3.79	$10.6K	-1.3%	Open the original filing on SEC.gov
Mar 2	Puri Raj K.	Chief Regulatory Officer	MEXER	5,470	—	—	+2.5%	Open the original filing on SEC.gov
Mar 2	Graf Finckenstein…	Chief Medical Officer	MEXER◆	3,907	—	—	—	Open the original filing on SEC.gov
Mar 2	Graf Finckenstein…	Chief Medical Officer	MEXER◆	8,790	—	—	—	Open the original filing on SEC.gov
Mar 2	Graf Finckenstein…	Chief Medical Officer	FTAX	7,122	$3.79	$27K	-5.7%	Open the original filing on SEC.gov
Mar 2	Graf Finckenstein…	Chief Medical Officer	MEXER	12,697	—	—	+11.4%	Open the original filing on SEC.gov
Mar 2	Bilinsky Igor	Chief Operating Officer	MEXER◆	3,517	—	—	—	Open the original filing on SEC.gov
Mar 2	Bilinsky Igor	Chief Operating Officer	MEXER◆	8,790	—	—	—	Open the original filing on SEC.gov
Mar 2	Bilinsky Igor	Chief Operating Officer	FTAX	6,903	$3.79	$26.2K	-5.9%	Open the original filing on SEC.gov
Mar 2	Bilinsky Igor	Chief Operating Officer	MEXER	12,307	—	—	+11.6%	Open the original filing on SEC.gov
Feb 24	Kirby Daniel Gordon	Chief Commercial Officer	MEXER◆	150,000	—	—	—	Open the original filing on SEC.gov
Feb 24	Kirby Daniel Gordon	Chief Commercial Officer	FTAX	34,165	$3.78	$129.1K	-19.7%	Open the original filing on SEC.gov
Feb 24	Kirby Daniel Gordon	Chief Commercial Officer	MEXER	120,000	—	—	+224.1%	Open the original filing on SEC.gov
Feb 10	Kirby Daniel Gordon	Chief Commercial Officer	MEXER◆	39,996	—	—	—	Open the original filing on SEC.gov
Feb 10	Kirby Daniel Gordon	Chief Commercial Officer	FTAX	16,450	$2.60	$42.8K	-23.5%	Open the original filing on SEC.gov
Feb 10	Kirby Daniel Gordon	Chief Commercial Officer	MEXER	39,996	—	—	+133.3%	Open the original filing on SEC.gov
Dec 2, 2025	Vogt Frederick G	Interim CEO & General…	MEXER◆	10,417	—	—	—	Open the original filing on SEC.gov
Dec 2, 2025	Vogt Frederick G	Interim CEO & General…	FTAX	4,426	$2.14	$9.5K	-0.9%	Open the original filing on SEC.gov
Dec 2, 2025	Vogt Frederick G	Interim CEO & General…	MEXER	10,417	—	—	+2.3%	Open the original filing on SEC.gov
Dec 2, 2025	Graf Finckenstein…	Chief Medical Officer	MEXER◆	3,906	—	—	—	Open the original filing on SEC.gov
Dec 2, 2025	Graf Finckenstein…	Chief Medical Officer	FTAX	1,984	$2.14	$4.2K	-1.8%	Open the original filing on SEC.gov

MEXER◆—

Puri Raj K. · Chief Regulatory…Sep 8

9,766 sh

FTAX$39K

Puri Raj K. · Chief Regulatory…Sep 8

4,478 sh @ $8.70 · -1.7% own

MEXER—

Puri Raj K. · Chief Regulatory…Sep 8

9,766 sh · +3.9% own

MEXER◆—

Bilinsky Igor · Chief Operating…Sep 8

7,813 sh

FTAX$34.6K

Bilinsky Igor · Chief Operating…Sep 8

3,976 sh @ $8.70 · -2.7% own

MEXER—

Bilinsky Igor · Chief Operating…Sep 8

7,813 sh · +5.7% own

MEXER◆—

Vogt Frederick G · Interim CEO &…Sep 8

15,626 sh

FTAX$57.8K

Vogt Frederick G · Interim CEO &…Sep 8

6,638 sh @ $8.70 · -1.1% own

MEXER—

Vogt Frederick G · Interim CEO &…Sep 8

15,626 sh · +2.7% own

MEXER◆—

Bilinsky Igor · Chief Operating…Sep 1

8,789 sh

FTAX$37K

Bilinsky Igor · Chief Operating…Sep 1

4,472 sh @ $8.28 · -3.1% own

MEXER—

Bilinsky Igor · Chief Operating…Sep 1

8,789 sh · +6.6% own

MEXER◆—

Puri Raj K. · Chief Regulatory…Sep 1

5,470 sh

FTAX$20.8K

Puri Raj K. · Chief Regulatory…Sep 1

2,508 sh @ $8.28 · -1.0% own

MEXER—

Puri Raj K. · Chief Regulatory…Sep 1

5,470 sh · +2.2% own

MEXER◆—

Vogt Frederick G · Interim CEO &…Sep 1

41,669 sh

FTAX$146.6K

Vogt Frederick G · Interim CEO &…Sep 1

17,702 sh @ $8.28 · -2.9% own

MEXER—

Vogt Frederick G · Interim CEO &…Sep 1

41,669 sh · +7.4% own

MEXER◆—

Kirby Daniel Gordon · Chief Commercial…Aug 10

10,001 sh

FTAX$15.6K

Kirby Daniel Gordon · Chief Commercial…Aug 10

2,436 sh @ $6.40 · -1.6% own

MEXER—

Kirby Daniel Gordon · Chief Commercial…Aug 10

10,001 sh · +6.8% own

MEXER◆—

Roche Corleen M. · Chief Financial…Aug 6

49,995 sh

FTAX$131.9K

Roche Corleen M. · Chief Financial…Aug 6

21,238 sh @ $6.21 · -42.5% own

MEXER—

Roche Corleen M. · Chief Financial…Aug 6

49,995 sh

AGRANT◆—

Weiser Michael · DirectorJun 16

90,316 sh

AGRANT◆—

Maynard Ryan D · DirectorJun 16

90,316 sh

AGRANT◆—

Puri Raj K. · Chief Regulatory…Jun 16

15,000 sh

AGRANT◆—

Dukes Iain D. · DirectorJun 16

180,632 sh

AGRANT◆—

Countouriotis Athena · DirectorJun 16

90,316 sh

MEXER◆—

Vogt Frederick G · Interim CEO &…Jun 5

15,625 sh

FTAX$28.1K

Vogt Frederick G · Interim CEO &…Jun 5

6,638 sh @ $4.23 · -1.2% own

MEXER—

Vogt Frederick G · Interim CEO &…Jun 5

15,625 sh · +2.8% own

MEXER◆—

Puri Raj K. · Chief Regulatory…Jun 5

9,766 sh

FTAX$16.3K

Puri Raj K. · Chief Regulatory…Jun 5

3,843 sh @ $4.23 · -1.5% own

MEXER—

Puri Raj K. · Chief Regulatory…Jun 5

9,766 sh · +4.0% own

MEXER◆—

Graf Finckenstein… · Chief Medical…Jun 5

7,813 sh

FTAX$16.8K

Graf Finckenstein… · Chief Medical…Jun 5

3,976 sh @ $4.23 · -2.8% own

MEXER—

Graf Finckenstein… · Chief Medical…Jun 5

7,813 sh · +5.7% own

MEXER◆—

Bilinsky Igor · Chief Operating…Jun 5

7,813 sh

FTAX$16.8K

Bilinsky Igor · Chief Operating…Jun 5

3,976 sh @ $4.23 · -2.9% own

MEXER—

Bilinsky Igor · Chief Operating…Jun 5

7,813 sh · +6.0% own

MEXER◆—

Vogt Frederick G · Interim CEO &…Jun 1

41,668 sh

FTAX$70.1K

Vogt Frederick G · Interim CEO &…Jun 1

17,701 sh @ $3.96 · -3.1% own

MEXER—

Vogt Frederick G · Interim CEO &…Jun 1

41,668 sh · +7.9% own

MEXER◆—

Puri Raj K. · Chief Regulatory…Jun 1

5,469 sh

FTAX$9.9K

Puri Raj K. · Chief Regulatory…Jun 1

2,508 sh @ $3.96 · -1.0% own

MEXER—

Puri Raj K. · Chief Regulatory…Jun 1

5,469 sh · +2.3% own

MEXER◆—

Graf Finckenstein… · Chief Medical…Jun 1

8,790 sh

FTAX$17.7K

Graf Finckenstein… · Chief Medical…Jun 1

4,473 sh @ $3.96 · -3.2% own

MEXER—

Graf Finckenstein… · Chief Medical…Jun 1

8,790 sh · +6.7% own

MEXER◆—

Bilinsky Igor · Chief Operating…Jun 1

8,790 sh

FTAX$17.7K

Bilinsky Igor · Chief Operating…Jun 1

4,473 sh @ $3.96 · -3.3% own

MEXER—

Bilinsky Igor · Chief Operating…Jun 1

8,790 sh · +7.0% own

MEXER◆—

Kirby Daniel Gordon · Chief Commercial…May 11

10,000 sh

FTAX$9K

Kirby Daniel Gordon · Chief Commercial…May 11

2,435 sh @ $3.70 · -1.6% own

MEXER—

Kirby Daniel Gordon · Chief Commercial…May 11

10,000 sh · +7.2% own

AGRANT◆—

Roche Corleen M. · Chief Financial…Mar 9

132,200 sh

AGRANT◆—

Vogt Frederick G · Interim CEO &…Mar 9

235,000 sh

AGRANT◆—

Puri Raj K. · Chief Regulatory…Mar 9

117,500 sh

AGRANT◆—

Kirby Daniel Gordon · Chief Commercial…Mar 9

132,200 sh

AGRANT◆—

Graf Finckenstein… · Chief Medical…Mar 9

58,750 sh

AGRANT◆—

Bilinsky Igor · Chief Operating…Mar 9

117,500 sh

MEXER◆—

Vogt Frederick G · Interim CEO &…Mar 5

62,493 sh

FTAX$122.5K

Vogt Frederick G · Interim CEO &…Mar 5

26,755 sh @ $4.58 · -4.8% own

MEXER—

Vogt Frederick G · Interim CEO &…Mar 5

62,493 sh · +12.7% own

MEXER◆—

Puri Raj K. · Chief Regulatory…Mar 5

39,059 sh

FTAX$84.1K

Puri Raj K. · Chief Regulatory…Mar 5

18,360 sh @ $4.58 · -7.1% own

MEXER—

Puri Raj K. · Chief Regulatory…Mar 5

39,059 sh · +17.9% own

MEXER◆—

Graf Finckenstein… · Chief Medical…Mar 5

31,246 sh

FTAX$75.7K

Graf Finckenstein… · Chief Medical…Mar 5

16,520 sh @ $4.58 · -11.1% own

MEXER—

Graf Finckenstein… · Chief Medical…Mar 5

31,246 sh · +26.7% own

MEXER◆—

Bilinsky Igor · Chief Operating…Mar 5

31,246 sh

FTAX$76.2K

Bilinsky Igor · Chief Operating…Mar 5

16,628 sh @ $4.58 · -11.7% own

MEXER—

Bilinsky Igor · Chief Operating…Mar 5

31,246 sh · +28.1% own

MEXER◆—

Vogt Frederick G · Interim CEO &…Mar 2

10,418 sh

MEXER◆—

Vogt Frederick G · Interim CEO &…Mar 2

41,669 sh

FTAX$86.4K

Vogt Frederick G · Interim CEO &…Mar 2

22,809 sh @ $3.79 · -4.4% own

MEXER—

Vogt Frederick G · Interim CEO &…Mar 2

52,087 sh · +11.2% own

MEXER◆—

Puri Raj K. · Chief Regulatory…Mar 2

5,470 sh

FTAX$10.6K

Puri Raj K. · Chief Regulatory…Mar 2

2,798 sh @ $3.79 · -1.3% own

MEXER—

Puri Raj K. · Chief Regulatory…Mar 2

5,470 sh · +2.5% own

MEXER◆—

Graf Finckenstein… · Chief Medical…Mar 2

3,907 sh

MEXER◆—

Graf Finckenstein… · Chief Medical…Mar 2

8,790 sh

FTAX$27K

Graf Finckenstein… · Chief Medical…Mar 2

7,122 sh @ $3.79 · -5.7% own

MEXER—

Graf Finckenstein… · Chief Medical…Mar 2

12,697 sh · +11.4% own

MEXER◆—

Bilinsky Igor · Chief Operating…Mar 2

3,517 sh

MEXER◆—

Bilinsky Igor · Chief Operating…Mar 2

8,790 sh

FTAX$26.2K

Bilinsky Igor · Chief Operating…Mar 2

6,903 sh @ $3.79 · -5.9% own

MEXER—

Bilinsky Igor · Chief Operating…Mar 2

12,307 sh · +11.6% own

MEXER◆—

Kirby Daniel Gordon · Chief Commercial…Feb 24

150,000 sh

FTAX$129.1K

Kirby Daniel Gordon · Chief Commercial…Feb 24

34,165 sh @ $3.78 · -19.7% own

MEXER—

Kirby Daniel Gordon · Chief Commercial…Feb 24

120,000 sh · +224.1% own

MEXER◆—

Kirby Daniel Gordon · Chief Commercial…Feb 10

39,996 sh

FTAX$42.8K

Kirby Daniel Gordon · Chief Commercial…Feb 10

16,450 sh @ $2.60 · -23.5% own

MEXER—

Kirby Daniel Gordon · Chief Commercial…Feb 10

39,996 sh · +133.3% own

MEXER◆—

Vogt Frederick G · Interim CEO &…Dec 2, 2025

10,417 sh

FTAX$9.5K

Vogt Frederick G · Interim CEO &…Dec 2, 2025

4,426 sh @ $2.14 · -0.9% own

MEXER—

Vogt Frederick G · Interim CEO &…Dec 2, 2025

10,417 sh · +2.3% own

MEXER◆—

Graf Finckenstein… · Chief Medical…Dec 2, 2025

3,906 sh

FTAX$4.2K

Graf Finckenstein… · Chief Medical…Dec 2, 2025

1,984 sh @ $2.14 · -1.8% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 60 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →